The enzyme as drug: application of enzymes as pharmaceuticals

M Vellard - Current opinion in biotechnology, 2003 - Elsevier
Enzymes as drugs have two important features that distinguish them from all other types of
drugs. First, enzymes often bind and act on their targets with great affinity and specificity …

Enzymatic wound debridement

J Ramundo, M Gray - Journal of Wound Ostomy & Continence …, 2008 - journals.lww.com
Background Clinical experience and existing research strongly support debridement as a
necessary component of wound bed preparation when slough or eschar is present. Multiple …

[HTML][HTML] Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update

C Hirche, SK Almeland, B Dheansa, P Fuchs… - Burns, 2020 - Elsevier
Abstract Introduction Bromelain-based Enzymatic Debridement has been introduced as an
additional concept to the burn surgeon's armamentarium and is best indicated for mid-to …

Digesting a path forward: the utility of collagenase tumor treatment for improved drug delivery

A Dolor, FC Szoka Jr - Molecular pharmaceutics, 2018 - ACS Publications
Collagen and hyaluronan are the most abundant components of the extracellular matrix
(ECM) and their overexpression in tumors is linked to increased tumor growth and …

[HTML][HTML] Towards extracellular matrix normalization for improved treatment of solid tumors

HS Abyaneh, M Regenold, TD McKee, C Allen… - Theranostics, 2020 - ncbi.nlm.nih.gov
It is currently challenging to eradicate cancer. In the case of solid tumors, the dense and
aberrant extracellular matrix (ECM) is a major contributor to the heterogeneous distribution …

Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report

L Rosenberg, O Lapid, A Bogdanov-Berezovsky… - Burns, 2004 - Elsevier
A prospective, non-comparative study design was used to describe our experience with a
bromelain-derived debriding agent, Debridase, in 130 patients with 332 deep second …

Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: An European consensus

C Hirche, A Citterio, H Hoeksema, J Koller, M Lehner… - Burns, 2017 - Elsevier
Early debridement and/or eschar removal is regarded as a significant step in the treatment of
deep partial and full thickness burns. It aims to control wound bioburden and allows early …

Optimal treatment of partial thickness burns in children: a systematic review

A Vloemans, MHE Hermans, MBA Van Der Wal… - Burns, 2014 - Elsevier
A large part of the patient population of a burn centre consists of children, most of whom are
younger than four years. The majority of these young children suffer from superficial and …

[图书][B] Microbiology of wounds

S Percival, K Cutting - 2010 - taylorfrancis.com
It is not the presence of microorganisms, but their interaction with patients that determines
their influence on wound healing. Documenting this critical but often ignored aspect of the …

Efficacy of enzymatic debridement of deeply burned hands

Y Krieger, A Bogdanov-Berezovsky, R Gurfinkel… - Burns, 2012 - Elsevier
BACKGROUND: The burned hand is a common and difficult to care-for entity in the field of
burns. Due to the anatomy of the hand (important and delicate structures crowded in a small …